Posted by Thomas Dobrow on Dec 14th, 2024
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 99,000 shares, an increase...
More of this article »